NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Healthy Skepticism site scrutinizes drug advertising to physicians

Posted By

Categories

Tags

Direct-to-consumer drug ads have drawn the scrutiny of federal regulators and some independent critics such as Consumer Reports. But the HealthySkepticism.org website and project has an AdWatch series that evaluates drug ads targeted at physicians in medical journals.

Pristiq2USA2008-08-20.jpgThe latest is an evaluation of this ad for Pristiq for depression. You should read the whole thing, but here’s an excerpt:

A superficial reading will mislead many people to the impression that the drug is an appropriate choice for major depressive disorder and perhaps wider indications. However, the advertisement does not provide any valid reasons for using this drug. As far as we are aware, there are no valid reasons for using this drug rather than other treatments when indicated. Since most health professionals are unlikely to give advertisements more than a superficial inspection, they are likely to be misled by this one.

You might also like

Comments

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Comments are closed.